Author:
Drainoni Mari-Lynn,Knudsen Hannah K.,Adams Kathy,Andrews-Higgins Shaquita A.,Auritt Vanessa,Back Sandi,Barkowski Laura K.,Batty Evan J.,Behrooz Melika R.,Bell Sydney,Chen Sadie,Christopher Mia-Cara,Coovert Nicolette,Crable Erika L.,Dasgupta Anindita,Goetz Michael,Goddard-Eckrich Dawn,Hartman Jeanie L.,Heffer Holly,Iftikhar Pulwasha,Jones Latasha,Lang Samantha,Lunze Karsten,Martin Anna,McCrimmon Tara,Reedy-Johnson Melissa K.,Roeber Carter,Scalise Ariel L.,Sieck Cynthia J.,Walker Daniel M.,Walt Galya,Wood Jennifer D.,Zito Priscilla,McAlearney Ann Scheck
Funder
National Institutes of Health
Subject
Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous),Pshychiatric Mental Health
Reference47 articles.
1. Substance Abuse and Mental Health Services Administration, 2017, Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.
2. Underutilization of medications to treat opioid use disorder: What role does stigma play?;Allen;Substance Abuse,2019
3. Do benefits restrictions limit medicaid acceptance in addiction treatment? Results from a national study;Andrews;Journal of Substance Abuse Treatment,2018
4. Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality;Beetham;Annals of Internal Medicine,2019
5. Addressing opioid overdose deaths: The vision for the HEALing communities study;Chandler;Drug and Alcohol Dependence,2020